LDL-Platelet Interaction Under Oxidative Stress Induces Macrophage Foam Cell Formation

• References

• 1 Aviram M. Effect of lipoproteins and platelets on macrophage cholesterol metabolism. In: Blood Cell Biochemistry. Harris JR. ed New York: Plenum Press Corporation; 1991. 2 179-208
• 2 Aviram M, Brook JG. Platelet enhancement of macrophage cholesterol accumulation: a novel mechanism foratherogenesis. In: Molecular Biology of Atherosclerosis. Proceeding of the 57th European Atherosclerosis Society Meeting Haipem MJ. ed John Libbey and Company Limited; London: 1992. 14 67-71
• 3 Aviram M, Fuhrman B, Brook JG. Platelet-mediated macrophage cholesterol accumulation. In: Atherosclerosis DC. Proceedings of the ninth International Symposium on Atherosclerosis,Rosemont-Chicago IL USA Stein O, Eisenberg S, ad Stein Y. eds. R and L Creative Communications Ltd; Tel-Aviv Israel: 1992. VI Thrombosis and Hemodynamics. 523-526
• 4 Aviram M. Beyond cholesterol: Modification of lipoproteins and increased atherogenicity. In: Atherosclerosis, Inflammation and Thrombosis. Neri Semeri GG, Gensini GF, Abbate R, Prisco D. eds. Scientific Press-Florence; Italy: 1993: 15-36
• 5 Aviram M, Brook JG. Platelet activation by plasma lipoproteins. Progress inCardiovascular Disease 1987; 30: 61-72
• 6 Brook JG, Aviram M. Platelet-lipoprotein Interaction. Seminars in Thromb and Haemosta 1988; 14 (03) 258-265
• 7 Aviram M. The effect of platelet on macrophage lipoprotein metabolism. Atherosclerosis 1988; 73: 269-271
• 8 Aviram M. Platelets and arterial wall lesion. In: Current Opinion in Lipidology Atherosclerosis: cell biology and lipoproteins. Coetzee GA, van der Westhuyzen DR. (Eds) 1992; 3 (05) 344-348
• 9 Sevitt S. Platelets and foam cells in the evolution of atherosclerosis. Histological and immunological studies of human lesions Atherosclerosis 1986; 61: 107-110
• 10 Ross R. Platelet derived growth factor. Annu Rev Medicine 1987; 38: 71-79
• 11 Hochgraf E, Levy Y, Aviram M, Brook JG, Cogan U. Lovastatin decreases plasma and platelet cholesterol levels and normalizes elevated platelet fluidity and aggregation in hypercholesterolemic patients. Metabolism 1994; 43: 11-17
• 12 Kruth HS. Platelet-mediated cholesterol accumulation in cultured aortic smooth muscle cells. Science 1985; 227: 1243-1245
• 13 Mendelsohn ME, Loscalzo J. Role of platelets in cholesteryl ester formation by U-937 cells. J Clin Invest 1988; 81: 62-68
• 14 Curtiss LK, Black AA, Takagi Y, Plow EF. New mechanisms for foam cell generation in atherosclerotic lesions. J Clin Invest 1987; 80: 367-373
• 15 Maor I, Brook JG, Aviram M. Platelet secreted lipoprotein-like particle is taken up by the macrophage scavenger receptor and enhances cellular cholesterol accumulation. Atherosclerosis 1991; 88: 163-174
• 16 Brown MS, Goldstein JL. Scavenger cell receptor shared. Ann Rev Biochemistry 1983; 52: 223-261
• 17 Aviram M. Modified forms of low density lipoprotein and atherosclerosis. Atherosclerosis 1993; 98: 1-9
• 18 Aviram M, Bierman EL, Chait A. Modification of low density lipoprotein by lipoprotein lipase or hepatic lipase induces enhanced uptake and cholesterol accumulation in cells. J Biol Chem 1988; 263: 15416-15422
• 19 Aviram M, Lund-Katz S, Phillips M, Chait A. The influence of the triglyceride content of low density lipoprotein on the interaction of apolipoprotein B-100 with cells. J Biol Chem 1988; 263: 16842-16848
• 20 Aviram M, Bierman EL, Oram JF. High density lipoprotein stimulates sterol translocation between intracellular and plasma membrane pools in human monocyte-derived macrophages. J Lipid Res 1989; 30: 65-76
• 21 Suits AG, Chait A, Aviram M, Heinecke JW. Phagocytosis of aggregated lipoprotein by macrophages: low density lipoprotein receptor dependent foam cell formation. Proc Natl Acad Sci USA 1989; 86: 2713-2717
• 22 Heinecke JW, Suits AG, Aviram M, Chait A. Phagocytosis of lipase-aggregated low density lipoprotein promotes macrophage foam cell formation. Sequential morphological and biochemical events Arteriosclerosis 1991; 11: 1643-1651
• 23 Aviram M, Keidar S, Rosenblat M, Brook JG. Reduced uptake of cholesterol esterase modified low density lipoprotein by macrophages. J.Biol Chem 1991; 266: 11567-11574
• 24 Aviram M, Maor I. Phospholipase A2-modified LDL is taken up at enhanced rate by macrophages. Biochem Biophys Res Commun 1992; 185: 465-472
• 25 Aviram M, Maor I. Phospholipase D modified low density lipoprotein is taken up by macrophages at increased rate: a possible role for phosphatidic acid. J Clin Invest 1993; 91: 1942-1952
• 26 Aviram M. Low density lipoprotein modification by cholesterol oxidase induces enhanced uptake and cholesterol accumulation in cells. J Biol Chem 1992; 267: 218-225
• 27 Aviram M. Platelet-modified low-density lipoprotein: studies in normals and in patient with homozygous familial hypercholesterolemia. Clin Biochem 1987; 20: 91-95
• 28 Aviram M, Fuhrman B, Keidar S, Maor I, Rosenblat M, Dankner G, Brook JG. Platelet-modified low density lipoprotein induces macrophage cholesterol accumulation and platelet activation. J Clin Chem Clin Biochem 1989; 27: 3-12
• 29 Phillips DR, Arnold K, Innerarity TL. Platelet secretory products inhibt lipoprotein metabolism in macrophages. Nature 1985; 316: 746-748
• 30 Aviram M. Platelet secretory products enhances LDL receptor activity and inhibit scavenger receptor activity in human monocyte-derived macrophages. Metabolism 1989; 38: 425-430
• 31 Fuhrman B, Brook JG, Aviram M. Lipid-protein particles secreted from activated platelets reduce macrophage uptake of low density lipoprotein. Atherosclerosis 1991; 89: 163-173
• 32 Fuhrman B, Brook JG, Aviram M. Proteins derived from platelet alpha granules modulate the uptake of oxidized low density lipoprotein by macrophages. Biochim Biophys Acta 1992; 1127: 15-21
• 33 Fuhiman B, Brook JG, Aviram M. Activated platelet secrete a protein- like factor that stimulates oxidized-LDL receptor activity in macrophages. J Lipid Res 1991; 32: 1113-1123
• 34 Hussein O, Brook JG, Aviram M. Intraperitoneal injection of platelet secretory products into mice increases macrophage uptake of oxidized low density lipoprotein. Israel: J Med Sci. 1993. 29 8 453-459
• 35 Aviram M, Fuhrman B, Maor I, Brook GJ. Serotonin increases macrophage uptake of oxidized low density lipoprotein. Eur. J. Clin. Chem. Clin Biochem 1992; 30: 55-61
• 36 Aviram M. Macrophage-mediated oxidation of LDL and atherosclerosis. In: Lipoprotein oxidation and Atherosclerosis: biological and clinical aspects. Bellomo G, Rice-Evans C. eds. Volume IX Richelieu Press; London, U.K.: 1995. in press
• 37 Aviram M. Antioxidant-mediated inhibiton of macrophage modification of low density lipoprotein. Life Chemistry Reports 1994; 12: 69-78
• 38 Hoffman R, Brook GJ, Aviram M. Hypolipidemic drags reduce lipoprotein susceptibility to undergo lipid peroxidation: in vitro and ex vivo studies. In: Mosby Year Book of Endocrinology. Bagdade JD. ed. 1993
• 39 Aviram M, Dankner G, Brook JG. Platelet secretory products increase LDL oxidation, enhance its uptake by macrophages and reduce its fluidity. Arteriosclerosis 1990; 10: 559-563
• 40 Keidar S, Kaplan M, Rosenblat M, Brook JG, Aviram M. Apolipoprotein E and lipoprotein lipase reduce macrophage degradation of oxidized VLDL but increase cellular degradation of native VLDL. 1192
• 41 Aviram M. The contribution of the macrophage receptor for oxidized LDL to its cellualaruptake. Biochim. Biophys. Res Commun 1991; 179: 359-365